A number of other equities analysts have also recently issued reports on the stock. Deutsche Bank raised shares of Nu Skin Enterprises from a hold rating to a buy rating and set a $60.00 price objective on the stock in a research report on Wednesday, May 1st. Bank of America reissued an underperform rating and set a $52.00 price objective (down previously from $57.00) on shares of Nu Skin Enterprises in a research report on Wednesday, June 19th. Citigroup cut their price objective on shares of Nu Skin Enterprises from $86.00 to $52.00 and set a buy rating on the stock in a research report on Thursday, July 18th. DA Davidson cut shares of Nu Skin Enterprises from a buy rating to a neutral rating and cut their price objective for the stock from $88.00 to $38.00 in a research report on Wednesday, July 17th. Finally, Jefferies Financial Group cut shares of Nu Skin Enterprises from a buy rating to a hold rating and set a $40.00 price objective on the stock. in a research report on Wednesday, July 17th. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $55.63.
Shares of NUS stock traded up $0.14 on Thursday, reaching $39.13. 553,592 shares of the company were exchanged, compared to its average volume of 891,424. The stock has a market capitalization of $2.16 billion, a P/E ratio of 11.12, a price-to-earnings-growth ratio of 1.07 and a beta of 0.67. The firm has a 50-day simple moving average of $45.17. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a one year low of $35.03 and a one year high of $88.68.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.